Checkpoints and immunity in cancers: Role of GNG12-Reference-Cited by-同舟云学术

Checkpoints and immunity in cancers: Role of GNG12

Published:2022-06 Issue: Volume:180 Page:106242
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Alausa Abdullahi,Victor Ugwu Chukwuebuka,Fadahunsi Olumide Samuel,Owolabi Nurudeen,Adeniji Adeolu,Olatinwo Mercy,Ogunlana Abdeen Tunde,Olaleke Barakat,Balogun Toheeb Adewale,Ogundepo Sunday,Adegbola Peter Ifeoluwa

Publisher

Elsevier BV

Subject

Pharmacology

Reference254 articles.

1. Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP;Ablasser;Nature,2013

2. Inflammation-driven carcinogenesis is mediated through STING;Ahn;Nat. Commun.,2014

3. Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors;Akbay;Cancer Disco,2013

4. Are macrophages in tumors good targets for novel therapeutic approaches?;Alahari;Mol. Cells,2015

5. PD- 1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome;Alsaab;Front. Pharm.,2017

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRISPRi with barcoded expression reporters dissects regulatory networks in human cells;2024-09-06

2. Dipeptide PA3264 derived from rare and endangered Squama Manis is a novel bioactive peptide for the treatment of triple-negative breast cancer;Chinese Medicine;2024-08-21

3. Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy;Discover Oncology;2024-08-11

4. Application of biomimetic nanovaccines in cancer immunotherapy: A useful strategy to help combat immunotherapy resistance;Drug Resistance Updates;2024-07

5. Expression patterns and clinical implications of PDL1 and DLL3 biomarkers in small cell lung cancer retrospectively studied: Insights for therapeutic strategies and survival prediction;Heliyon;2024-03